The Latest Breaking News from Allegion

Despite Allegion’s outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.

Allegion shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 83.

Allegion has recently lagged behind its industry peers, and analysts are cautious about the stock's future.

Due to Allegion’s underperformance relative to the broader market in 2024, Wall Street analysts remain cautious about the stock’s prospects.

Allegion is gearing up to announce its third-quarter results later this month, and analysts are projecting marginal earnings dip.

Allegion outperformed the broader sector recently, but Wall Street analysts remain cautious about the stock’s prospects.

As Allegion underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Allegion’s (ALLE) solid second-quarter performance demonstrates the resilience of its business model. Given the steady demand for its innovative security solutions, strategic partnerships and acquisitions, and rapid market expansion, let’s determine if Allegion makes a compelling choice for investors looking for attractive returns. Read more to find out.

Allegion shows improving price performance, earning an upgrade to its IBD Relative Strength Rating